Why it’s hard to stomach big pharma’s complaints about Covid vaccine patent waivers
The patent system exists to reward innovation but it has been abused on repeated occasions by drug companies. If a waiver gets vaccines to where they are needed then refuseniks, including the UK, should fall into line with Joe Biden, writes James Moore
No, nay, never, was the reaction of the pharmaceutical industry to America’s potentially game-changing move to back a vaccine patent waiver in an attempt to improve global supplies.
The argument of the drug companies is: innovation would be stifled, threatening the development of future treatments, and that would be disastrous for patients.
Do they have a point?
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies